https://blog.priceplow.com/podcast/michael-goodman-ftc-warning-letters-103

In April of 2023, the Federal Trade Commission (FTC) unexpectedly sent warning letters to about 700 drug companies and dietary supplement brands regarding substantiation of their product claims. Their letters stated that there was no active investigation, and that “The fact that a company is on this list is NOT an indication that it has done anything wrong”, but it obviously raised a great deal of concern in both industries.

To find out what was going on, and to get a general lesson in the concerns of the Federal Trade Commission, we brought on FTC subject matter expert Michael Goodman of Hudson Cook, LLP to explain the story. We retained Michael for a check-up on our website in 2018, and kept in touch because of his excellent work.

In this podcast, we get a great lesson on what the FTC cares about in terms of misleading product claims, and the legal process a company will find themselves in when the agency comes knocking on their door.

As for those FTC warning letters, the long story short is that they’re an unforeseen side effect of a 2021 Supreme Court decision, and were sent as a preemptive measure in case the FTC were ever to want to seek financial penalties. In four words: “The clock has started”.

Check it out on YouTube (video below), Spotify, or any RSS-enabled podcast app:

https://www.youtube.com/watch?v=l8r6nz52m2c

Detailed Show Notes with FTC Legal Expert Michael Goodman of Hudson Cook, LLP

Important Links: